CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance the development of bioartificial pancreases to treat type 1 diabetes by improving the robustness of surrogate beta cells and using better encapsulation materials. The goal is to increase the survival and functionality of transplanted cells, ultimately providing a viable treatment for diabet…
The proposed project aims at making a substantial contribution to the success of bioartificial pancreases and thus to a cure for type 1 diabetes (T1D).
The latter is an autoimmune disease that destroys pancreatic beta cells which are responsible for insulin production.
Mostly it strikes at a young age.
Patients depend on frequent insulin injections for the rest of their life.
Despite these burdensome injections, acute and long-term complications are frequent and often severe.
Beta cell transplan…
VIVIT, VORARLBERG INSTITUTE FOR VASCULAR INVESTIGATION AND TREATEMENT- VORARLBERG INSTITUT FUR VASCULAREMEDIZIN VEREIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
